Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) on Monday, soared 3.96% from the previous trading day, before settling in for the closing price of $16.91. Within the past 52 weeks, ARCT’s price has moved between $14.93 and $45.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 310.16% over the past five years. The company achieved an average annual earnings per share of -151.01%. With a float of $24.58 million, this company’s outstanding shares have now reached $26.83 million.
Let’s look at the performance matrix of the company that is accounted for 180 employees. In terms of profitability, gross margin is 102.49%, operating margin of -37.01%, and the pretax margin is -39.91%.
Arcturus Therapeutics Holdings Inc (ARCT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arcturus Therapeutics Holdings Inc is 9.27%, while institutional ownership is 88.43%. The most recent insider transaction that took place on Oct 15 ’24, was worth 249,121. In this transaction Chief Scientific Officer & COO of this company sold 12,000 shares at a rate of $20.76, taking the stock ownership to the 435,334 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Officer proposed sale 12,000 for $20.76, making the entire transaction worth $249,121.
Arcturus Therapeutics Holdings Inc (ARCT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -151.01% per share during the next fiscal year.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Arcturus Therapeutics Holdings Inc (ARCT) is currently performing well based on its current performance indicators. A quick ratio of 4.76 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.21, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.11 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) saw its 5-day average volume 0.53 million, a positive change from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 40.91%. Additionally, its Average True Range was 1.47.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 24.20%, which indicates a significant decrease from 39.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.62% in the past 14 days, which was higher than the 65.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.16, while its 200-day Moving Average is $26.46. Nevertheless, the first resistance level for the watch stands at $18.15 in the near term. At $18.73, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.14. If the price goes on to break the first support level at $17.16, it is likely to go to the next support level at $16.75. The third support level lies at $16.17 if the price breaches the second support level.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
Market capitalization of the company is 471.74 million based on 27,087K outstanding shares. Right now, sales total 166,800 K and income totals -29,730 K. The company made 41,670 K in profit during its latest quarter, and -6,900 K in sales during its previous quarter.
